SMART DAK Cervical Cancer Screening
0.0.1 - ci-build
SMART DAK Cervical Cancer Screening, published by Dan Heslinga (independent contributor). This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/dhes/smart-dak-cxca/ and changes regularly. See the Directory of published versions
The decision-support logic encodes A/641 (2020) 2.2 (eligibility), Fig 2.4 (HPV result routing), and 2.2 (eligibility), Fig 2.4 (HPV result routing), and
The active decision artifacts are:
CXCAD2DTScreeningEligibility — full four-outcome HPV-pathway eligibility (legal-binding, A/641 §2.2 ages 35 and 45)CXCAD2DTScreeningEligibility-Cytology — sibling for the cytology-only-facility 11-age cycle (legal-binding)CXCAMNGD2DTScreeningEligibility-Programmatic — Mongolia overlay for the April 2025 launch's 30/40 announcement (programmatic)CXCAD2DTHPVResultRouting — three-outcome routing tree per A/641 Fig 2.4CXCAD18SRecallScheduling — seven timeout-trigger recall rules per A/641 §2.3All PlanDefinitions reference shared CQL libraries; the CXCAElements library is the harmonization substrate — both decision-support and quality-measure libraries consume it. See Adapting Guidelines for Country Use for the methodology rationale, including the bindingness model that lets the legal and programmatic-overlay PlanDefinitions co-exist.
For the full inventory of CQL Libraries and ActivityDefinitions see the Artifact Index.